Paying users zone. Data is covered by 
.
Get to Amgen Inc. for $17.99, or
get to whole website for at least 3 months from $49.99.
Statement of Comprehensive Income
Difficulty: Beginner
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Amgen Inc., Consolidated Statement of Comprehensive Income
USD $ in millions
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income | |
|
|
|
|
||||||
| Foreign currency translation gains (losses) | |
|
|
|
|
||||||
| Effective portion of cash flow hedges | |
|
|
|
|
||||||
| Net unrealized gains (losses) on available-for-sale securities | |
|
|
|
|
||||||
| Other | |
|
|
|
|
||||||
| Other comprehensive income (loss), net of tax | |
|
|
|
|
||||||
| Comprehensive income | |
|
|
|
|
| Item | Description | The company |
|---|---|---|
| Foreign currency translation gains (losses) | Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity, net of tax, attributable to the parent entity. | Amgen Inc.'s foreign currency translation gains (losses) increased from 2015 to 2016 and from 2016 to 2017. |
| Effective portion of cash flow hedges | Net of tax effect change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges, after taxes, that is attributable to the parent entity. A cash flow hedge is a hedge of the exposure to variability in the cash flows of a recognized asset or liability or a forecasted transaction that is attributable to a particular risk. The change includes an entity's share of an equity investee's increase (decrease) in deferred hedging gains or losses. | Amgen Inc.'s effective portion of cash flow hedges declined from 2015 to 2016 and from 2016 to 2017. |
| Net unrealized gains (losses) on available-for-sale securities | Gross appreciation or the gross loss in value of the total unsold securities at the end of an accounting period, after tax, attributable to the parent entity. | Amgen Inc.'s net unrealized gains (losses) on available-for-sale securities increased from 2015 to 2016 but then slightly declined from 2016 to 2017. |
| Comprehensive income | The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. | Amgen Inc.'s comprehensive income increased from 2015 to 2016 but then declined significantly from 2016 to 2017. |
